Pancreatic Cancer Research

ResearcherNational Hospital OrganizationActive in the last 2 years

Hirotaka Tashiro

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2615-8183; OpenAlex author ID A5013608005. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 7

  1. Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors. Co-author DOI 10.1007/s12328-026-02388-z↗
  2. TMPRSS4 Expression Predicts Survival and Benefit from Neoadjuvant Chemotherapy in Pancreatic Cancer. Last author DOI 10.1245/s10434-026-20228-9↗
  3. ASO Visual Abstract: TMPRSS4 Expression Predicts Survival and Benefit From Neoadjuvant Chemotherapy in Pancreatic Cancer. Last author DOI 10.1245/s10434-026-20329-5↗
  4. Effects of transmembrane serine protease 4 on the survival in patients with pancreatic ductal adenocarcinoma undergoing surgery followed by adjuvant chemothera… Last author DOI 10.1007/s00595-024-02824-y↗
  5. Effect of body fat mass loss on prognosis of radical resection for pancreatic ductal adenocarcinoma based on bioelectrical impedance analysis. Co-author DOI 10.1186/s12893-024-02315-4↗
  6. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.14670/hh-18-397↗
  7. [A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer]. Last author PMID 29362317↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takeshi Sudo · 7 shared papers, 2018–2026 · strength 1.40
  2. Yosuke Shimizu · 3 shared papers, 2026 · strength 0.79
  3. Shinya Takahashi · 3 shared papers, 2026 · strength 0.79
  4. Kenta Baba · 3 shared papers, 2026 · strength 0.79
  5. Sho Tazuma · 3 shared papers, 2024–2026 · strength 0.69
  6. Atsushi Yamaguchi · 3 shared papers, 2022–2024 · strength 0.54
  7. Kenichiro Uemura · 2 shared papers, 2024–2026 · strength 0.50
  8. Yoshiyuki Shibata · 2 shared papers, 2024 · strength 0.40
  9. Shin’ya Takahashi · 2 shared papers, 2024 · strength 0.40
  10. Akira Ishikawa · 2 shared papers, 2022–2024 · strength 0.35
  11. Tatsuaki Sumiyoshi · 1 shared paper, 2026 · strength 0.29
  12. Wataru Yasuif · 1 shared paper, 2022 · strength 0.15
  13. Naoto Hadano · 1 shared paper, 2022 · strength 0.15
  14. Masahiro Tanemura · 1 shared paper, 2018 · strength 0.07
  15. Tatsuya Miyamoto · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.